Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | |
|---|---|---|---|---|---|
| Operating cash flow (direct method) | |||||
| Cash income from operating activities | -52.08%993.27K | 83.52%2.07M | 163.63%1.13M | -12.52%428.41K | 489.73K |
| Revenue from customers | -41.63%638.73K | 59.05%1.09M | 1,173.41%688.07K | -51.72%54.03K | --111.92K |
| Income from government grants | -63.76%354.54K | 121.67%978.36K | 17.89%441.35K | --374.38K | ---- |
| Other cash income from operating activities | ---- | ---- | ---- | ---- | --377.81K |
| Cash paid | 24.15%-3.43M | -26.77%-4.52M | -6.91%-3.57M | -39.06%-3.34M | -2.4M |
| Payments to suppliers for goods and services | 24.15%-3.43M | -26.77%-4.52M | -6.91%-3.57M | -39.06%-3.34M | ---2.4M |
| Direct interest paid | ---23.82K | ---- | -2,273.25%-44.68K | -8.38%2.06K | --2.24K |
| Direct interest received | 1,298.53%118.85K | 149.50%8.5K | --3.41K | ---- | ---- |
| Operating cash flow | 4.05%-2.34M | 1.55%-2.44M | 14.70%-2.48M | -52.36%-2.91M | ---1.91M |
| Investing cash flow | |||||
| Cash flow from continuing investing activities | 2,576.68%88.15K | 99.43%-3.56K | -3,561.21%-626.87K | 97.20%-17.12K | -610.57K |
| Net PPE purchase and sale | 141.93%30.84K | -31.37%-73.56K | -375.30%-56K | 76.66%-11.78K | ---50.49K |
| Net intangibles purchas and sale | ---- | ---- | ---- | ---- | ---260.08K |
| Net business purchase and sale | -18.14%57.3K | 105.95%70K | -21,927.39%-1.18M | 98.22%-5.34K | ---300K |
| Net investment purchase and sale | ---- | ---- | ---7.12K | ---- | ---- |
| Cash from discontinued investing activities | |||||
| Investing cash flow | 2,576.68%88.15K | 99.43%-3.56K | -3,561.21%-626.87K | 97.20%-17.12K | ---610.57K |
| Financing cash flow | |||||
| Cash flow from continuing financing activities | 351.54%14.48M | 21.04%3.21M | 3,926.53%2.65M | -101.06%-69.26K | 6.52M |
| Net issuance payments of debt | 87.73%-205.1K | -237.06%-1.67M | 289,018.48%1.22M | -100.05%-422 | --870.6K |
| Net common stock issuance | 184.73%14.72M | 232.61%5.17M | --1.55M | ---- | --5.69M |
| Interest paid (cash flow from financing activities) | ---- | ---258.28K | ---- | ---- | ---- |
| Net other financing activities | 56.62%-27.31K | 74.42%-62.95K | -78.79%-246.14K | -54.90%-137.67K | ---88.88K |
| Cash from discontinued financing activities | |||||
| Financing cash flow | 351.54%14.48M | 21.04%3.21M | 3,926.53%2.65M | -101.06%-69.26K | --6.52M |
| Net cash flow | |||||
| Beginning cash position | 110.44%1.46M | -39.34%691.51K | -72.44%1.14M | 3,067.85%4.14M | --130.55K |
| Current changes in cash | 1,501.40%12.23M | 267.68%763.73K | 84.78%-455.46K | -174.80%-2.99M | --4M |
| Effect of exchange rate changes | ---6.94K | ---- | 295.20%7.03K | -171.35%-3.6K | --5.05K |
| End cash Position | 839.96%13.68M | 110.44%1.46M | -39.34%691.51K | -72.44%1.14M | --4.14M |
| Free cash from | 5.70%-2.37M | 0.82%-2.51M | 13.12%-2.53M | -31.56%-2.92M | ---2.22M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |